- Home
- UPWK vs JANX Comparison
UPWK vs JANX Comparison
Compare UPWK & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPWK
- JANX
- Stock Information
- Founded
- UPWK 2013
- JANX 2017
- Country
- UPWK United States
- JANX United States
- Employees
- UPWK N/A
- JANX N/A
- Industry
- UPWK EDP Services
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- UPWK Technology
- JANX Health Care
- Exchange
- UPWK Nasdaq
- JANX Nasdaq
- Market Cap
- UPWK 1.7B
- JANX 1.6B
- IPO Year
- UPWK 2018
- JANX 2021
- Fundamental
- Price
- UPWK $13.32
- JANX $29.79
- Analyst Decision
- UPWK Buy
- JANX Strong Buy
- Analyst Count
- UPWK 13
- JANX 7
- Target Price
- UPWK $18.75
- JANX $94.29
- AVG Volume (30 Days)
- UPWK 1.7M
- JANX 985.8K
- Earning Date
- UPWK 05-05-2025
- JANX 05-13-2025
- Dividend Yield
- UPWK N/A
- JANX N/A
- EPS Growth
- UPWK 2286.76
- JANX N/A
- EPS
- UPWK 1.52
- JANX N/A
- Revenue
- UPWK $769,325,000.00
- JANX $10,588,000.00
- Revenue This Year
- UPWK N/A
- JANX N/A
- Revenue Next Year
- UPWK $7.31
- JANX $250.58
- P/E Ratio
- UPWK $8.75
- JANX N/A
- Revenue Growth
- UPWK 11.64
- JANX 30.99
- 52 Week Low
- UPWK $8.43
- JANX $22.52
- 52 Week High
- UPWK $18.14
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- UPWK 51.32
- JANX 47.07
- Support Level
- UPWK $12.76
- JANX $31.34
- Resistance Level
- UPWK $13.75
- JANX $33.97
- Average True Range (ATR)
- UPWK 0.37
- JANX 1.56
- MACD
- UPWK 0.11
- JANX 0.31
- Stochastic Oscillator
- UPWK 69.93
- JANX 30.85
About UPWK Upwork Inc.
Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with skilled independent professionals. The company develops platform for hiring and freelancing purposes. Its products offering include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The business generates revenue from Talent and Clients across the USA, India, the Philippines and the rest of the world. Substantial income is derived from providing services to clients.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.